Jon Cohen Biography and Net Worth

SVP of OPKO Health

Jon Cohen is 66, he's been the Director and Executive Chairman of BioReference Laboratories of Opko Health Inc since 2020. There are 7 older and 6 younger executives at Opko Health Inc. The oldest executive at Opko Health Inc is John Paganelli, 85, who is the Independent Director.

What is Jon R. Cohen's net worth?

The estimated net worth of Jon R. Cohen is at least $165,000.00 as of May 10th, 2021. Dr. Cohen owns 125,000 shares of OPKO Health stock worth more than $165,000 as of May 19th. This net worth evaluation does not reflect any other investments that Dr. Cohen may own. Learn More about Jon R. Cohen's net worth.

How do I contact Jon R. Cohen?

The corporate mailing address for Dr. Cohen and other OPKO Health executives is 4400 BISCAYNE BLVD., MIAMI FL, 33137. OPKO Health can also be reached via phone at (305) 575-4100 and via email at [email protected]. Learn More on Jon R. Cohen's contact information.

Has Jon R. Cohen been buying or selling shares of OPKO Health?

Jon R. Cohen has not been actively trading shares of OPKO Health during the last ninety days. Most recently, on Monday, May 10th, Jon R. Cohen bought 50,000 shares of OPKO Health stock. The stock was acquired at an average cost of $3.81 per share, with a total value of $190,500.00. Following the completion of the transaction, the senior vice president now directly owns 125,000 shares of the company's stock, valued at $476,250. Learn More on Jon R. Cohen's trading history.

Who are OPKO Health's active insiders?

OPKO Health's insider roster includes Jon Cohen (SVP), and Phillip Frost (CEO). Learn More on OPKO Health's active insiders.

Are insiders buying or selling shares of OPKO Health?

In the last twelve months, OPKO Health insiders bought shares 26 times. They purchased a total of 10,792,012 shares worth more than $11,319,625.39. The most recent insider tranaction occured on May, 17th when CEO Phillip Md Et Al Frost bought 163,997 shares worth more than $211,556.13. Insiders at OPKO Health own 47.3% of the company. Learn More about insider trades at OPKO Health.

Information on this page was last updated on 5/17/2024.

Jon R. Cohen Insider Trading History at OPKO Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2021Buy50,000$3.81$190,500.00125,000View SEC Filing Icon  
See Full Table

Jon R. Cohen Buying and Selling Activity at OPKO Health

This chart shows Jon R Cohen's buying and selling at OPKO Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OPKO Health Company Overview

OPKO Health logo
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: $1.32
Low: $1.27
High: $1.36

50 Day Range

MA: $1.19
Low: $0.87
High: $1.40

2 Week Range

Now: $1.32
Low: $0.85
High: $2.24


2,821,700 shs

Average Volume

11,627,572 shs

Market Capitalization

$920.03 million

P/E Ratio


Dividend Yield